EUVIMEDEUVIMED entdecken
Crossref

Immune regulation of TLR4/MYD88/ NF-κB/AP1/IL-6 pathway and modulation of aldosterone/PPARα receptors by eplerenone and fenofibrate in ovarian ischemia reperfusion induced injury

Marwa Monier Mahmoud Refaie, Elshymaa A Abdel-Hakeem, Sayed Shehata, Shereen Mohammed Mohammed Elsaghir, Sahar Ahmed Mokhemer, Nagwa Zenhom Mustafa Ahmed, Samar Hisham Elsayed, Aya Aly Ashraf Abdel Mageed, Heba Reda Mohamed, Heba A Shawky, Doaa Mohamed Elroby Ali

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Marwa Monier Mahmoud Refaie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Minia University, 61511, El-Minia, Egypt; Faculty of Medicine, Minia National University, El…. Hauptthemen laut MEDLINE: Fenofibrate, Ovary, Eplerenone, Reperfusion Injury. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The immune system is deeply involved in the pathogenesis of different gynecological disorders including ovarian torsion that commonly occurs during surgical manipulation or within ovarian masses, affecting not only the ovaries, but it has remote effect on different organs particularly cardiac tissue. Early intervention and proper medical treatment are so important to preserve the ovaries and prevent distant organ damage. Accordingly, the aim of this work was to evaluate the possible ameliorative role of eplerenone (EPL) or fenofibrate (FEN) on ovarian and cardiac affection in an experimental model of ovarian ischemia/reperfusion (OIR). METHOD: Fifty female Wistar albino rats were divided into five groups (n = 10); control, OIR induced group, OIR plus EPL (100 mg/kg), OIR plus FEN (300 mg/kg), OIR plus EPL (100 mg/kg) plus FEN (300 mg/kg). RESULTS: OIR could induce ovarian injury with remote cardiac damage. Data of current study revealed significant increases of the cardiac enzymes, and malondialdehyde (MDA) levels but decreases of total anti-oxidant capacity (TAC) and reduced glutathione (GSH) levels. Moreover, there were increases in toll like receptor 4 (TLR4), myeloid differentiation primary response 88 (MYD88), activation protein 1 (AP1), interleukin 6 (IL-6), nuclear factor kappa b (NF-κB) and cleaved caspase-3 with abnormal histological features. However, EPL or FEN co-administration alone or in combination reversed OIR damaging effects by antagonizing aldosterone action by EPL, anti-inflammatory, anti-oxidant, and anti-apoptotic features with modulation of peroxisome proliferator activated receptor alpha (PPARα) by FEN and TLR4/MYD88/ NF-κB/AP1/IL-6 pathway. Interestingly, co-administration of both drugs showed more improvement than giving each one alone. CONCLUSION: EPL and/or FEN had ameliorative properties against OIR induced harmful effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FenofibrateOvaryEplerenoneReperfusion InjuryOvarian DiseasesAnimalsFemaleToll-Like Receptor 4Myeloid Differentiation Factor 88Rats, WistarNF-kappa BRatsPPAR alphaSignal TransductionInterleukin-6AldosteroneDisease Models, Animal

Stichwörter der Autor:innen

AldosteroneEplerenoneFenofibrateOvarian ischemia reperfusionPeroxisome proliferator activated receptor alphaToll like receptor4

Substanzen

FenofibrateToll-Like Receptor 4Myeloid Differentiation Factor 88NF-kappa BTlr4 protein, ratEplerenonePPAR alphaMyd88 protein, ratInterleukin-6Aldosterone

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Faculty of Medicine, Minia University, 61511, El-Minia, Egypt; Faculty of Medicine, Minia National University, El-Minia, Egypt. Electronic address: marwamonier@mu.edu.eg.
  • Department of Medical Physiology, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt; Faculty of Medicine, Minia National University, El-Minia, Egypt.
  • Department of Cardiology, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt.
  • Department of Internal medicine, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt.
  • Department of Histology and Cell Biology, Faculty of Medicine, Minia University, 61511, El-Minia, Egypt, and Faculty of Oral and Dental Medicine, Lotus University, 61768, El-Minia, Egypt; Faculty of Medicine, Minia Nati…
  • Department of Medical Biochemistry, Faculty of Medicine, Minia University, 61511 El-Minia, Egypt; Department of Biochemistry, Faculty of Medicine, Al-Baha University, Albaha 65525, Saudi Arabia.

Zitieren

APA

Refaie, M. M. M., Abdel-Hakeem, E. A., Shehata, S., Elsaghir, S. M. M., Mokhemer, S. A., Ahmed, N. Z. M., Elsayed, S. H., Mageed, A. A. A. A., Mohamed, H. R., Shawky, H. A., & Ali, D. M. E. (2025). Immune regulation of TLR4/MYD88/ NF-κB/AP1/IL-6 pathway and modulation of aldosterone/PPARα receptors by eplerenone and fenofibrate in ovarian ischemia reperfusion induced injury. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115113

Vancouver

Refaie MMM, Abdel-Hakeem EA, Shehata S, Elsaghir SMM, Mokhemer SA, Ahmed NZM, et al. Immune regulation of TLR4/MYD88/ NF-κB/AP1/IL-6 pathway and modulation of aldosterone/PPARα receptors by eplerenone and fenofibrate in ovarian ischemia reperfusion induced injury. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115113

BibTeX
@article{Refaie2025,
  author = {Refaie, Marwa Monier Mahmoud and Abdel-Hakeem, Elshymaa A and Shehata, Sayed and Elsaghir, Shereen Mohammed Mohammed and Mokhemer, Sahar Ahmed and Ahmed, Nagwa Zenhom Mustafa and Elsayed, Samar Hisham and Mageed, Aya Aly Ashraf Abdel and Mohamed, Heba Reda and Shawky, Heba A and Ali, Doaa Mohamed Elroby},
  title = {Immune regulation of TLR4/MYD88/ NF-κB/AP1/IL-6 pathway and modulation of aldosterone/PPARα receptors by eplerenone and fenofibrate in ovarian ischemia reperfusion induced injury},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115113}
}
Kostenlos starten →